Clinical Trial of an Improved Melanoma Vaccine

Bystryn, Jean-Claude

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Exploratory/Developmental Grants (R21)
• Project #: 1R21CA066669-01A1
• Application #: 2110107
• Study Section: Experimental Therapeutics Subcommittee 1 (ET)
• Project Start: 1996-03-01
• Project End: 1998-02-28
• Budget Start: 1996-03-01
• Budget End: 1997-02-28
• Support Year: 1
• Fiscal Year: 1996

Institution

• Name: New York University
• Department: Dermatology
• Type: Schools of Medicine
• City: New York
• State: NY
• Country: United States
• Zip Code: 10016

Publications

Reynolds, S R; Celis, E; Sette, A et al. (1998) HLA-independent heterogeneity of CD8+ T cell responses to MAGE-3, Melan-A/MART-1, gp100, tyrosinase, MC1R, and TRP-2 in vaccine-treated melanoma patients. J Immunol 161:6970-6